JP2002114791A - Method for producing galanthamine type lycoris alkaloids - Google Patents

Method for producing galanthamine type lycoris alkaloids

Info

Publication number
JP2002114791A
JP2002114791A JP2000339731A JP2000339731A JP2002114791A JP 2002114791 A JP2002114791 A JP 2002114791A JP 2000339731 A JP2000339731 A JP 2000339731A JP 2000339731 A JP2000339731 A JP 2000339731A JP 2002114791 A JP2002114791 A JP 2002114791A
Authority
JP
Japan
Prior art keywords
group
producing
reaction
compound
galantamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000339731A
Other languages
Japanese (ja)
Inventor
Manabu Noide
學 野出
Kiyoji Nishide
喜代治 西出
Sumiaki Kodama
純明 児玉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP2000339731A priority Critical patent/JP2002114791A/en
Publication of JP2002114791A publication Critical patent/JP2002114791A/en
Pending legal-status Critical Current

Links

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

PROBLEM TO BE SOLVED: To develop a method for chemically synthesizing a galanthamine type alkaloid efficiently, more concretely, capable of extremely improving a chemical yield of an intramolecular coupling reaction being the most important in a synthetic process. SOLUTION: This production method is a structural improvement of a substrate of an intramolecular coupling reaction, a phenol derivative is used as one of two kinds of phenyl groups and a pyrogallol derivative symmetrically containing three oxygen-substituted groups is used as the other. A reaction yield can be more extremely improved than a conventional method by the reaction.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明が属する技術分野】本発明は、新規な分子内カッ
プリング体を高収率で合成する方法を特徴とするガラン
タミン型ヒガンバナアルカロイド類の製造方法に関する
ものである。
TECHNICAL FIELD The present invention relates to a method for producing galantamine-type amaryllidaceae alkaloids, which comprises a method for synthesizing a novel intramolecularly coupled product in high yield.

【0002】[0002]

【従来の技術】人類の高齢化が進む中で、老人性痴呆症
が社会問題となってきている。この老人性痴呆症の多く
はアルツハイマー病であり、アセチルコリンエステラー
ゼ阻害活性を有する物質がその治療に有効であることが
知られている。ガランタミンは上記阻害活性を有し、現
在治験段階にあることからこのガランタミンとその誘導
体の効率的な化学合成法の確立が望まれている。
2. Description of the Related Art As humanity ages, senile dementia has become a social problem. Most of this senile dementia is Alzheimer's disease, and it is known that substances having acetylcholinesterase inhibitory activity are effective for the treatment. Galantamine has the above-mentioned inhibitory activity and is currently in a clinical trial stage. Therefore, it is desired to establish an efficient chemical synthesis method of galantamine and its derivatives.

【0003】ガランタミン型アルカロイド類の化学合成
に関する研究は1960年代から報告があるが、上記の
ような背景から近年も新規化学合成に関する報告は数多
い。例えば、N−(4−hydroxypheneth
yl)−N−(2−bromo−5−hydroxy−
4−methoxybenzyl)formamidや
N−(3−bromo−4−hydroxyphene
thyl)−N−(2−bromo−5−hydrox
y−4−methoxybenzyl)formam−
ideを基質としてフェリシアン化カリによる酸化的カ
ップリング反応(Szewczyk,et al.,
J.Heterocyclic Chem.1995,
32,195;Szewczyk,et al.,J.
Heterocyclic Chem.1988,
,1809;Czollner,et al.,Te
trahedron Letters,1998,
,2087;Henshilwood,etal.,
US Patent 6,084,094)、および、
N−[2,2−diphenyl−6−(trimet
hyl−silanyl)benzo[1,3]dio
xol−5−ylmethyl]−2,2,2−tri
fluoro−N−[2−(4−hydroxy−ph
enyl)ethyl]acetamideを基質とし
てフェニルヨージン(III)ビス(トリフルオロアセ
タート)(Kita,Y.,et al.,J.Or
g.Chem.,1998,63,6625;北 泰行
等、特開平11−80170)による酸化的カップリン
グ反応などがある。これら既知合成法における最大の問
題は分子内カップリング反応の化学収率であり、50%
を越える収率の報告が皆無であるのが実情であり、現在
のところ、高収率、製造工程の簡易さ、等を具備した産
業上有効なガランタミン型ヒガンバナアルカノイドの化
学合成法は極めて困難な課題であったといえる。
[0003] Studies on the chemical synthesis of galantamine-type alkaloids have been reported since the 1960s, but in recent years there have been many reports on new chemical synthesis from the above background. For example, N- (4-hydroxypheneth)
yl) -N- (2-bromo-5-hydroxy-
4-methyoxybenzyl) formamide or N- (3-bromo-4-hydroxyphene)
thyl) -N- (2-bromo-5-hydroxy)
y-4-methoxybenzyl) formam-
Oxidative coupling reaction with potassium ferricyanide using ide as a substrate (Szewczyk, et al.,
J. Heterocyclic Chem. 1995,
32 , 195; Szewczyk, et al. , J. et al.
Heterocyclic Chem. 1988, 2
5 , 1809; Czollner, et al. , Te
Trahedron Letters, 1998, 3
9 , 2087; Henshirwood, et al. ,
US Patent 6,084,094), and
N- [2,2-diphenyl-6- (trimet
hyl-silanyl) benzo [1,3] dio
xol-5-ylmethyl] -2,2,2-tri
fluoro-N- [2- (4-hydroxy-ph
phenyliodine (III) bis (trifluoroacetate) (Kita, Y., et al., J. Or)
g. Chem. , 1998, 63 , 6625; Yasuyuki Kita et al., JP-A-11-80170). The biggest problem with these known synthetic methods is the chemical yield of the intramolecular coupling reaction, which is 50%.
At present, there is no report of a yield exceeding that, and at present, it is extremely difficult to chemically synthesize an industrially effective galantamine-type Amaryllidaceae alkanoid with high yield, simplicity of the production process, and the like. It can be said that it was an issue.

【0004】[0004]

【発明が解決しようとする課題】本発明は、ガランタミ
ン型アルカロイド類の効率的な化学合成法の開発であ
り、より具体的には合成プロセス中最も重要な分子内カ
ップリング反応の化学収率を大幅に向上させることを課
題としている。
SUMMARY OF THE INVENTION The present invention is directed to the development of an efficient chemical synthesis of galantamine-type alkaloids. More specifically, the present invention is intended to reduce the chemical yield of the most important intramolecular coupling reaction during the synthesis process. The task is to greatly improve it.

【0005】[0005]

【課題を解決するための手段】この出願の発明は、上記
の課題を解決するものとして、一般式
Means for Solving the Problems The invention of this application is based on a general formula for solving the above problems.

【化1】(式中のRは炭化水素または酸素原子が含ま
れる炭化水素もしくはトリアルキルシリル基の保護基
を、Rはアミド結合からなる保護基を示す)で表され
るフェノール誘導体を超原子価ヨー素試薬と反応させ
て、一般式
Wherein R 1 represents a protecting group for a hydrocarbon or a hydrocarbon containing an oxygen atom or a trialkylsilyl group, and R 2 represents a protecting group comprising an amide bond. After reacting with a hypervalent iodine reagent, the general formula

【化2】の化合物を製造することを特徴とする分子内カ
ップリング体の製造方法(請求項1)を提供する。そし
て、この出願の発明は、上記製造方法における反応を超
原子価ヨー素(III)試薬としての、次式 PhI(OCOCF で表されるフェニルヨージン(III)ビス(トリフル
オロアセタート):(phenyliodine(II
I)bis(trifluoroacetate)を用
いて行うこと(請求項2)やフルオロ置換アルコール類
を溶媒として行う方法(請求項3)をはじめ、Rの保
護基は、ベンジル基、ベンジルオキシメチル基、メトキ
シメチル基、メトキシエチル基、メトキシベンジル基、
アリル基もしくは次式 RSi− (R、RおよびRは炭化水素を示す)で表される
ものとする(請求項4)、Rのアミド結合からなる保
護基は、次式 R−CO− (Rは水素原子またはフルオロ置換炭化水素を示す)
で表されるものとする方法(請求項5)等をもその態様
として提供する。また、本発明は、一般式
A method for producing an intramolecularly coupled compound (claim 1), which comprises producing the compound of the formula (1), is provided. The invention of this application, the reaction in the production method as hypervalent iodine (III) reagent, phenyl iodide emissions (III) bis (trifluoroacetate represented by the following formula PhI (OCOCF 3) 2 ) :( phenyliodine (II)
I) The protecting group of R 1 may be benzyl, benzyloxymethyl, methoxy, or the like, including bis (trifluoroacetate) (claim 2) and a method using a fluoro-substituted alcohol as a solvent (claim 3). Methyl group, methoxyethyl group, methoxybenzyl group,
An allyl group or a protective group consisting of an amide bond of R 2 , which is represented by the following formula: R 3 R 4 R 5 Si— (R 3 , R 4 and R 5 represent a hydrocarbon) (claim 4) Is represented by the following formula: R 6 —CO— (R 6 represents a hydrogen atom or a fluoro-substituted hydrocarbon)
A method (claim 5) and the like represented by the following formula (1) is also provided as the embodiment. In addition, the present invention has a general formula

【化3】(式中のRは、水酸基、置換基を有していて
もよいアルコキシ基、アシルオキシ基またはアシル基も
しくは環構成の炭素原子とともにカルボニル基を形成す
る酸素原子を示し、Rは、水素原子または置換基を有
していてもよい炭化水素基を示す)で表されるガランタ
ミン(galanthamine)型ヒガンバナアルカ
ロイド(Amaryllidaceae alkalo
id)類の製造方法であって、前記のいずれかの分子内
カップリング体の製造工程を含むことを特徴とするガラ
ンタミン型ヒガンバナアルカロイド類の製造方法(請求
項6)、さらにはこの方法の実施に際し、一般式
## STR3 ## (R 7 in the formula represents a hydroxyl group, an optionally substituted alkoxy group, an oxygen atom to form an acyloxy group or an acyl group or a carbonyl group together with the carbon atoms of the ring structure, R 9 Represents a hydrogen atom or a hydrocarbon group which may have a substituent)) galantamine-type amaryllidaceae alkaloid (Amaryllidaceae alkalo)
A method for producing galantamine-type amaryllidaceae alkaloids (claim 6), which comprises a method for producing any of the above-mentioned intramolecularly coupled products (claim 6). The general formula

【化4】(式中のRは、炭化水素または酸素原子が含ま
れる炭化水素もしくは有機ケイ素基の保護基を示す)で
表されるフェノール誘導体を、フェニルヨージン(II
I)ビス(トリフルオロアセタート)と反応させて分子
内カップリング体を生成させるガランタミン型ヒガンバ
ナアルカロイド類の製造方法(請求項7)等も特徴的な
ものとして提供する。
Wherein R represents a hydrocarbon or a hydrocarbon containing an oxygen atom or a protecting group for an organosilicon group, and a phenol derivative represented by the following formula:
I) A method for producing galantamine-type amaryllidaceae alkaloids which form an intramolecularly coupled product by reacting with bis (trifluoroacetate) (claim 7) is also provided as a characteristic feature.

【0006】[0006]

【発明の実施の形態】この出願の発明は、上記のとおり
の特徴をもつものであるが、基本的にはヒガンバナアル
カロイド類の共通生合成中間体であるノルベラジン(n
orbelladine)の分子内カップリング反応の
反応部位によって多種の骨格を生みだしているとの観点
に立脚している。ガランタミン型ヒガンバナアルカロイ
ド類はノルベラジンのp−o’カップリング反応により
生成されていることになる。
BEST MODE FOR CARRYING OUT THE INVENTION The invention of this application has the above-mentioned features, but basically, norverazine (n) which is a common biosynthesis intermediate of amaryllidaceae alkaloids
orbelladine), which generates various kinds of skeletons depending on the reaction site of the intramolecular coupling reaction. Galantamine-type amaryllidaceae alkaloids are produced by the po 'coupling reaction of norverazine.

【0007】この発明の方法は、上記p−o’カップリ
ング反応が選択的に進行するノルベラジン誘導体を企画
合成し、これをカップリング反応に用いることによりガ
ランタミン型骨格を収率よく合成することを大きな特徴
としているのである。カップリング反応には企画合成し
たフェノール誘導体を用い、カップリング試薬としては
超原子価ヨー素(III)試薬、たとえば、次式 PhI(OCOCF のフェニルヨージン(III)ビス(トリフルオロアセ
タート)との反応により分子内カップリング体としての
前記の
The method of the present invention aims at synthesizing a galanthamine-type skeleton with high yield by designing and synthesizing a norverazine derivative in which the above p-o 'coupling reaction proceeds selectively and using it for the coupling reaction. It is a big feature. A phenol derivative designed and synthesized is used for the coupling reaction, and a hypervalent iodine (III) reagent such as phenyliodin (III) bis (trifluoroacetate of the following formula PhI (OCOCF 3 ) 2 is used as the coupling reagent. And the above-mentioned compound as an intramolecular coupling product

【化2】の化合物を製造することにより実施される。This is carried out by producing the compound of the following formula.

【0008】超原子価ヨー素(III)試薬としては、
前記のフェニルヨージン(III)ビス(トリフルオロ
アセタート)だけでなく、たとえば、PhI(OAc)
、PhI=O、PhI(OH)(OTs)、PhIC
等のものが考慮される。
The hypervalent iodine (III) reagent includes:
Not only the above-mentioned phenyliodin (III) bis (trifluoroacetate) but also, for example, PhI (OAc)
2 , PhI = O, PhI (OH) (OTs), PhIC
those of l 2, etc. are considered.

【0009】[0009]

【化1】における符号Rは、炭化水素または酸素原子
が含まれる炭化水素基もしくは有機ケイ素基の保護基を
示し、このうち炭化水素基としてはアルキル基、シクロ
アルキル基、シクロアルキルアルキル基、アルケニル基
等の脂肪族炭化水素や、ベンジル基、トリチル基などの
アラルキル基、およびメトキシメチル基やメトキシベン
ジル基等の酸素原子を含む脂肪族炭化水素やアラルキル
基が例示され、有機ケイ素基についても各種のものであ
ってよく、有機シリル基、有機シリルオキシ基等があ
り、なかでも前記のシリル基 RSi− (R、R、およびRは炭化水素を示す)が好まし
いとして例示される。
The symbol R 1 in the formula represents a hydrocarbon or a protecting group for a hydrocarbon group containing an oxygen atom or an organosilicon group, wherein the hydrocarbon group is an alkyl group, a cycloalkyl group, a cycloalkylalkyl group, Aliphatic hydrocarbons such as alkenyl groups, aralkyl groups such as benzyl and trityl groups, and aliphatic hydrocarbons and aralkyl groups containing oxygen atoms such as methoxymethyl and methoxybenzyl groups are also exemplified. There may be various kinds, such as an organic silyl group and an organic silyloxy group. Among them, the above-mentioned silyl group R 3 R 4 R 5 Si— (R 3 , R 4 and R 5 represent hydrocarbons) is preferred. Exemplified as preferred.

【0010】Rのアミド結合からなる保護基について
は窒素原子の保護基の役割を果たすものであって、次式 R−CO− (Rは水素原子または炭化水素基もしくはフルオロ置
換炭化水素を示す)を示し、ホルミル基とトリフルオロ
アセチル基等が好ましいとして例示される。
The protecting group consisting of an amide bond of R 2 serves as a protecting group for a nitrogen atom, and has the following formula: R 6 —CO— (R 6 is a hydrogen atom or a hydrocarbon group or a fluoro-substituted hydrocarbon) And formyl group and trifluoroacetyl group are exemplified as preferable.

【化1】のフェノール誘導体を、たとえば前記のフェニ
ルヨージン(III)ビス(トリフルオロアセタート)
と反応させる場合には、通常は反応温度として−50〜
10℃程度、両者のモル比は1/3〜3/1程度とする
ことができ、これは限定的ではない。また、反応溶媒と
しては、アセトニトリル、ジクロロメタン、トリフルオ
ロ酢酸、およびフルオロ置換アルコール類があげられる
が、トリフルオロエタノール類が好適に用いられる。以
上のカップリング反応は、この発明においてより具体的
に、前記の
The phenol derivative of the formula is converted, for example, to the above-mentioned phenyliodin (III) bis (trifluoroacetate)
When reacting, usually the reaction temperature is -50 to
The temperature can be about 10 ° C., and the molar ratio of both can be about 1/3 to 3/1, and this is not limited. Examples of the reaction solvent include acetonitrile, dichloromethane, trifluoroacetic acid, and fluoro-substituted alcohols, and trifluoroethanol is preferably used. The above coupling reaction is more specifically described in the present invention.

【化3】で表されるガランタミン型ヒガンバナアルカロ
イド類の製造のための1工程として有効に採用されるこ
とになる。この場合のカップリング反応では、たとえば
前記のように、
This is effectively adopted as one step for the production of galantamine-type amaryllidaceae alkaloids represented by the following formula. In the coupling reaction in this case, for example, as described above,

【化4】のフェノール誘導体が反応基質として使用され
る。
A phenol derivative of the formula is used as a reaction substrate.

【0011】後述の実施例においてその合成が例示説明
されているヒガンバナアルカロイドgalantham
ine(1)、narwedine(2)、lycor
amine(3)は既に合成の例が報告されているが、
この発明による合成法は、従来法に比して、以下の点で
特徴を有している。1)従来法での分子内カップリング
反応はその化学収率が50%を越える報告はないのに対
して、本発明の反応では80%を越える化学収率が得ら
れ、従来法に比して化学収率が大幅に改善されている。
The amaryllidaceae alkaloid galantham, whose synthesis is illustrated in the examples which follow.
ine (1), nearwedine (2), lycor
As for amine (3), an example of synthesis has already been reported.
The synthesis method according to the present invention has the following features as compared with the conventional method. 1) The chemical yield of the intramolecular coupling reaction by the conventional method has not been reported to exceed 50%, whereas the chemical yield of the reaction of the present invention exceeds 80%. The chemical yield has been greatly improved.

【0012】分子内カップリング反応の化学収率改善の
狙いは、従来法の反応基質の構造的改良であり、2種の
フェニル基の一方にフェノール誘導体を用い、他方に3
個の酸素置換基を対称的にもつピロガロール誘導体を用
いた点にある。すなわち、上記反応基質のカップリング
反応における結合部位は、フェノール誘導体のp−位と
ピロガロール誘導体の2つの無置換炭素位(o−位)に
限られ、その2つの炭素位置は等価であり、どちらと結
合しても同一のカップリング体を生成するように設計さ
れているためである。カップリング反応の基質にピロガ
ロール誘導体の使用は、清水ら(Shimizu,et
al.,Chem.Pharm.Bull.,197
8,26,3765;Shimizu,et al.,
Heterocycles,1997,,277)に
よっても使用されているが、清水らの場合はフェノール
部にL−チロシンを用いた不斉合成であるため合成経路
が複雑となり、また、カップリング試薬も本合成法と異
なっている。上記カップリング反応の試薬は、北等によ
り既に報告(Kita,et al.,Chem.Co
mmun.,1996,1481;Kita,et a
l.,J.Org.Chem.,1996,61,58
57)されている毒性の低い酸化剤phenyliod
ine(III)bis(trifluoroacet
ate)(PIFA)を用いており、従来から使用され
てきた毒性の高い重金属酸化剤等を用いない点も特徴の
1つである。
The aim of improving the chemical yield of the intramolecular coupling reaction is to improve the structure of the conventional reaction substrate by using a phenol derivative for one of the two phenyl groups and a phenol derivative for the other.
The point is that a pyrogallol derivative having two oxygen substituents symmetrically is used. That is, the binding site in the coupling reaction of the reaction substrate is limited to the two unsubstituted carbon positions (o-positions) of the phenol derivative and the pyrogallol derivative, and the two carbon positions are equivalent. This is because they are designed to generate the same coupling body even when they are combined. The use of pyrogallol derivatives as substrates for coupling reactions has been described by Shimizu et al.
al. Chem. Pharm. Bull. , 197
8, 26 , 3765; Shimizu, et al. ,
Heterocycles, 1997, 8 , 277), but in the case of Shimizu et al., The synthesis route is complicated due to the asymmetric synthesis using L-tyrosine in the phenol moiety, and the coupling reagent is also used in this synthesis. Is different from the law. Reagents for the above coupling reaction have already been reported by Kita et al. (Kita, et al., Chem. Co.)
mmun. Kita, et a, 1996 , 1481;
l. , J. et al. Org. Chem. , 1996, 61 , 58
57) Phenyliod, a less toxic oxidizing agent
ine (III) bis (trifluoroacet)
ate) (PIFA), and one of the features is that a conventionally used highly toxic heavy metal oxidizing agent or the like is not used.

【0013】上記カップリング反応の反応混合物からカ
ップリング体
From the reaction mixture of the above coupling reaction, a coupling product

【化2】の単離操作が極めて簡便であることである。す
なわち、後述の実施例において例示されているように、
カップリング反応後、反応溶媒を減圧下で留去した残渣
に酢酸エチルエステルを加えて結晶化させることにより
高収率でカップリング体
The isolation operation of the formula is extremely simple. That is, as exemplified in the examples described below,
After the coupling reaction, the reaction solvent is distilled off under reduced pressure.

【化2】が単離される。これは、上記反応基質のカップ
リング体
Is isolated. This is a coupling product of the above reaction substrate

【化2】が有機溶媒に極めて難溶であるという性質を利
用しているためであり、経済的に優れ大量合成に特に有
用である。カップリング体の製造はこの発明のガランタ
ミン型アルカロイド類の製造工程として欠かせないもの
であるが、カップリング反応の反応基質の製造、および
得られたカップリング体から各種のガランタミン型アル
カロイドが化学合成される。本特許に開示する新しいカ
ップリング反応により高収率で合成される代表的ガラン
タミン型アルカロイドをそれらの構造式とともに図1に
示す。これらの最終生成物の製造には、化学合成で知ら
れている各種の単位反応操作が適宜に採用される。これ
らの個々の反応については以下の実施例としてもその特
徴を説明することができる。
This is due to the fact that ## STR2 ## is extremely insoluble in organic solvents, and is economically excellent and particularly useful for mass synthesis. The production of the coupling product is an indispensable step in the production of the galantamine-type alkaloids of the present invention.However, the production of the reaction substrate for the coupling reaction, and the various galantamine-type alkaloids are chemically synthesized from the obtained coupling product. Is done. Representative galantamine-type alkaloids synthesized in high yield by the novel coupling reaction disclosed in this patent are shown in FIG. 1 along with their structural formulas. In producing these final products, various unit reaction operations known in chemical synthesis are appropriately employed. The characteristics of these individual reactions can be described in the following examples.

【0014】[0014]

【発明の効果】本発明の合成法によればヒガンバナアル
カロイドの合成に際し、分子内カップリングの化学収率
が80%以上の高収率が得られ、しかも反応生成物から
のカップリング体の単離操作が極めて容易であるという
特徴を有する。
According to the synthesis method of the present invention, in the synthesis of Amaryllidaceae alkaloid, a high chemical yield of intramolecular coupling of 80% or more can be obtained, and a single product of the coupled product from the reaction product can be obtained. It has the feature that the separation operation is extremely easy.

【0015】[0015]

【実施例】実施例1 Norbelladine誘導体のカップリング反応に
よりgalanthamine型alkaloid骨格
の合成norbelladine誘導体のカップリング
反応を位置選択的に行うため、norbelladin
eのカテコール部に各種置換基で保護したピロガロール
誘導体を用い、norbelladineの2級アミン
部は2種の置換基で保護された反応基質(12)を合成
した。これらの合成は、カテコール誘導体で行われてい
る既知の方法に準じ、市販の没食子酸のメチルエステル
6から誘導したアルデヒド体10とtyramineと
を縮合し、その後sodium borohydrid
eによる還元反応により生成する2級アミンをトリフル
オロアセチル化、またはホルミル化して収率良く得た。
これらの反応プロセスを図2に示す。なお基質12a〜
12iは全て新規化合物である。
Example 1 Synthesis of a galanthamine-type alkaloid skeleton by a coupling reaction of a norbelladine derivative In order to perform a coupling reaction of a norbelladine derivative regioselectively, norbelladine was used.
Using a pyrogallol derivative protected with various substituents for the catechol part of e, a reaction substrate (12) in which the secondary amine part of norbelladine was protected with two kinds of substituents was synthesized. In these syntheses, tyramines are condensed with aldehyde 10 derived from a commercially available gallic acid methyl ester 6 and then sodium borohydride according to a known method carried out with a catechol derivative.
The secondary amine produced by the reduction reaction with e was trifluoroacetylated or formylated to obtain a good yield.
These reaction processes are shown in FIG. In addition, the substrate 12a ~
12i are all new compounds.

【0016】次いで、基質12をphenyliodi
ne(III)bis(trifluoroaceta
te)(PIFA)と反応させると、位置選択的に反応
したp−o’カップリン体13または14が得られた。
その反応プロセルを図3に示す。反応の収率はトリフル
オロエタノール(CFCHOH)を反応溶媒に用い
たとき、一般的に従来の報告における収率以上で得られ
た。特にRにメチル基、R’にホルミル基を用いた12
bでは定量的な収率で13bが得られ、Rにベンジル基
を用いた12dでも82%という極めて高い化学収率で
目的物13dが形成された。基質12の各種化合物(1
2a−12i)から得られる各種カップリン体(13ま
たは14)の反応収率を第1表に示す。
Next, the substrate 12 is replaced with phenyliodi.
ne (III) bis (trifluoroaceta
te) By reacting with (PIFA), regioselectively reacted po-coupling derivative 13 or 14 was obtained.
The reaction process is shown in FIG. When trifluoroethanol (CF 3 CH 2 OH) was used as a reaction solvent, the yield of the reaction was generally higher than the yield reported in the conventional reports. Particularly, a methyl group is used for R and a formyl group is used for R ′.
With b, 13b was obtained in a quantitative yield, and even with 12d using a benzyl group for R, the target compound 13d was formed with a very high chemical yield of 82%. Various compounds of substrate 12 (1
Table 1 shows the reaction yields of various types of coupling products (13 or 14) obtained from 2a-12i).

【0017】カップリング体13からgalantha
mine型alkaloid骨格への合成には、ピロガ
ロール部の脱保護と余分な水酸基の還元的除去を行う必
要がある。カップリング反応が高収率で進行した13b
と13cの脱メチル化は三臭化ホウ素により副生成物を
生成するため、13d〜13iのピロガロール部の脱保
護を検討した。この結果、たとえば、次の反応工程にも
示したように、13dのベンジル基は−78℃で三塩化
ホウ素を用いるか、室温下でトリフルオロ酢酸とジメチ
ルスルフィドの混液により収率よく除去できた。上記反
応により生成した2つのフェノール性水酸基の1つは同
時にジエノン部にマイケル型付加を起して14bが得ら
れ、残ったフェノール性水酸基はトリフルオロメタンス
ルホン酸無水物によりトリフラートとした後、パラジウ
ム(0)を触媒としたギ酸による還元反応によりgal
anthamine型alkaloid骨格の16を高
収率で得た。これらの反応プロセスを図4に示す。
From the coupling body 13 galantha
In order to synthesize a min-type alkaloid skeleton, it is necessary to deprotect the pyrogallol moiety and reductively remove excess hydroxyl groups. 13b where the coupling reaction proceeded in high yield
Since demethylation of 13c and 13c generates a by-product with boron tribromide, deprotection of the pyrogallol portion of 13d to 13i was studied. As a result, for example, as shown in the next reaction step, the benzyl group of 13d could be removed in good yield by using boron trichloride at -78 ° C or by mixing trifluoroacetic acid and dimethyl sulfide at room temperature. . One of the two phenolic hydroxyl groups generated by the above reaction simultaneously causes a Michael-type addition to the dienone moiety to give 14b. Gal) by a reduction reaction with formic acid using
Anthamine-type alkaloid skeleton 16 was obtained in high yield. These reaction processes are shown in FIG.

【0018】<合成1−1> N−3’,5’−Dihydroxy−4’−meth
oxyphenylmethyl−4−hydroxy
phenylethylamine(11a)の合成 窒素気流下、10a(840mg,5mmol)のdr
y methanol(15ml)溶液にthyram
ine(720mg,5.25mmol)を加え、室温
にて25分撹拌した。反応終了後、氷冷下、反応液にs
odiumborohydride(190mg,5m
mol)を徐々に加え、氷冷下にて20分間撹拌し、そ
の後、室温にて50分間撹拌した。反応終了後、反応溶
液にdry iceを加えて析出物を濾取し濾液の溶媒
を留去して得られた粗生成物をシリカゲルカラムクロマ
トグラフィーで精製し、11a(1.43g,99%)
を得た。 無色結晶;H−NMR(d−DMSO)δ:6.9
7 and 6.65(AB type,J=8.5H
z,4H,Ar−H),6.26(s,2H,Ar−
H),3.65(s,3H,OMe),3.50(s,
2H,CH),2.7−2.6(m,4H,CH
).
<Synthesis 1-1> N-3 ', 5'-Dihydroxy-4'-meth
oxyphenylmethyl-4-hydroxy
Synthesis of phenylethylamine (11a) Dr of 10a (840 mg, 5 mmol) under nitrogen stream
Thyram in y methanol (15ml) solution
Ine (720 mg, 5.25 mmol) was added, and the mixture was stirred at room temperature for 25 minutes. After completion of the reaction, add s
odiumborohydride (190mg, 5m
mol) was slowly added, and the mixture was stirred under ice cooling for 20 minutes, and then stirred at room temperature for 50 minutes. After completion of the reaction, dry ice was added to the reaction solution, and the precipitate was collected by filtration. The solvent of the filtrate was distilled off, and the obtained crude product was purified by silica gel column chromatography to obtain 11a (1.43 g, 99%).
I got Colorless crystals; 1 H-NMR (d 6 -DMSO) δ: 6.9
7 and 6.65 (AB type, J = 8.5H
z, 4H, Ar-H), 6.26 (s, 2H, Ar-
H), 3.65 (s, 3H, OMe), 3.50 (s,
2H, CH 2), 2.7-2.6 ( m, 4H, CH 2 C
H 2).

【0019】<合成1−2> N−3’,5’−Dibenzyloxy−4’−me
thoxyphenylmethyl−4−hydro
xyphenylethylamine(11c)の合
成 窒素気流下、10c(5.0g,14.4mmol)の
dry methanol(100ml)溶液にthy
ramine(3.9g,28.7mmol)を加え、
70℃にて70分還流した。反応終了後、氷冷下、反応
液にsodium borohydride(0.6
g,15.8mmol)を加え、氷冷下にて30分間撹
拌し、その後、室温にて40分間撹拌した。反応終了
後、溶媒を留去して得られた粗生成物をethylac
etate抽出した。抽出液を飽和食塩水で洗浄し、無
水硫酸ナトリウムで乾燥、濾過後、溶媒を留去して得ら
れた粗生成物をmethanolで結晶化し11c
(5.5g,81%)を得た。 無色結晶;H−NMR(CDCl,400MHz)
δ:7.41−7.26(m,10H),6.96
(d,J=8.4Hz,2H),6.66(d,J=
8.4Hz,2H),6.54(s,2H,Ar−
H),5.02(s,4H),3.86(s,3H),
3.64(s,2H),2.78(t,J=6.0H
z,2H),2.70(t,J=6.2Hz,2H).
<Synthesis 1-2> N-3 ', 5'-Dibenzyloxy-4'-me
thoxyphenylmethyl-4-hydro
Synthesis of xyphenylethylamine (11c) A solution of 10c (5.0 g, 14.4 mmol) in dry methanol (100 ml) was added under a nitrogen stream.
Ramine (3.9 g, 28.7 mmol) was added,
Reflux at 70 ° C. for 70 minutes. After the reaction was completed, sodium borohydride (0.6%) was added to the reaction solution under ice cooling.
g, 15.8 mmol), and the mixture was stirred under ice-cooling for 30 minutes, and then stirred at room temperature for 40 minutes. After completion of the reaction, the crude product obtained by distilling off the solvent was purified with ethylac
Eate was extracted. The extract was washed with a saturated saline solution, dried over anhydrous sodium sulfate, filtered, and then the solvent was distilled off. A crude product obtained was crystallized from methanol to obtain 11c.
(5.5 g, 81%). Colorless crystals; 1 H-NMR (CDCl 3 , 400 MHz)
δ: 7.41-7.26 (m, 10H), 6.96
(D, J = 8.4 Hz, 2H), 6.66 (d, J =
8.4 Hz, 2H), 6.54 (s, 2H, Ar-
H), 5.02 (s, 4H), 3.86 (s, 3H),
3.64 (s, 2H), 2.78 (t, J = 6.0H)
z, 2H), 2.70 (t, J = 6.2 Hz, 2H).

【0020】<合成1−3> N−3’,5’−Dihydroxy−4’−meth
oxyphenylmethyl−N−(4−ydro
xyphenylethyl)trifluoroac
etoamide(12a)の合成 窒素気流下、11a(1.43g,4.9mmol)の
pyridine(15ml)溶液に氷冷撹拌下tri
fluoroacetic anhydride(2.
07ml,15mmol)を滴下し、0℃にて20分間
撹拌した。反応終了後、溶媒を留去して得られた粗生成
物をethyl acetate抽出した。抽出液を飽
和炭酸水素ナトリウム水溶液、飽和食塩水で洗浄し、無
水硫酸マグネシウムで乾燥、濾過後、溶媒を留去して得
られた粗生成物をシリカゲルカラムクロマトグラフィー
(chloroform:methanol=10:
1)で精製し、12a(1.17g,63%)を結晶状
粉末として得た。 H−NMR(CDCl)δ:7.00(d,J=
8.8Hz,2H,Ar−H),6.78 and
6.76(d,J=8.8Hz,2H,Ar−H),
6.38 and 6.28(s,2H,Ar−H),
5.64(brs,2H,OH),4.98(brs,
1H,OH),4.48and 4.22(s,2H,
CH),3.88 and 3.87(s,3H,O
Me),3.52−5.42(m,2H,CH),
2.84−2.74(m,2H,CH).
<Synthesis 1-3> N-3 ', 5'-Dihydroxy-4'-meth
oxyphenylmethyl-N- (4-ydro
xyphenylethyl) trifluoroac
Synthesis of etoamide (12a) A solution of 11a (1.43 g, 4.9 mmol) in pyridine (15 ml) under a nitrogen stream was stirred under ice-cooling and stirring.
Fluoroacetic anhydride (2.
(07 ml, 15 mmol) was added dropwise and stirred at 0 ° C. for 20 minutes. After completion of the reaction, the solvent was distilled off, and the crude product obtained was extracted with ethyl acetate. The extract was washed with a saturated aqueous solution of sodium hydrogencarbonate and saturated saline, dried over anhydrous magnesium sulfate, filtered, and the solvent was distilled off. The resulting crude product was subjected to silica gel column chromatography (chloroform: methanol = 10:
Purification in 1) gave 12a (1.17 g, 63%) as a crystalline powder. 1 H-NMR (CDCl 3 ) δ: 7.00 (d, J =
8.8 Hz, 2H, Ar-H), 6.78 and
6.76 (d, J = 8.8 Hz, 2H, Ar-H),
6.38 and 6.28 (s, 2H, Ar-H),
5.64 (brs, 2H, OH), 4.98 (brs,
1H, OH), 4.48 and 4.22 (s, 2H,
CH 2 ), 3.88 and 3.87 (s, 3H, O
Me), 3.52-5.42 (m, 2H , CH 2),
2.84-2.74 (m, 2H, CH 2 ).

【0021】<合成1−4> N−3’,4’,5’−Trimethoxyphen
ylmethyl−N−(4−hydroxyphen
ylethyl)formamide(12b)の合成 窒素気流下、市販の3,4,5−trimethoxy
benzaldehyde(10b)(2.0g,0.
01mol)のmethanol(15ml)溶液に氷
冷下、市販のthyramine hydrochlo
ride(1.74g,0.01mol),molec
ular sieves 4A(2.5g),trie
thylamine(1.39mL,0.01mol)
を加え、室温にて48時間撹拌した。反応終了後、不溶
物を濾過により除去し、氷冷下、濾液にsodiumb
orohydride(756mg,0.02mol)
を加え、室温にて3時間撹拌した。反応終了後、反応液
を1N−HClに注いで中和し、溶媒を減圧留去した。
残査をethyl acetateで抽出した後、有機
層を飽和食塩水で洗浄し、無水硫酸ナトリウムで乾燥、
濾過後、溶媒を減圧留去して粗生成物を得た。得られた
粗生成物をシリカゲルカラムクロマトグラフィー(el
uent;hexane:ethyl acetate
=1:1)で精製し11bを得た。窒素気流下、11b
(1.10g)にformic acid(0.5m
L),ethyl formate(74mL,1mo
l)を加え、70℃で10時間還流した。反応終後、不
溶物を濾過により除去し、濾液から溶媒を留去して得ら
れた粗生成物をシリカゲルカラムクロマトグラフィー
(eluent;hexane:ethyl acet
ate=1:1)で精製し12b(1.475g,42
%from10b)を得た。 無色結晶;H−NMR(CDCl,300MHz)
δ:8.24 and7.83(2s,1H),7.0
2(d,J:8.0Hz,1H),6.90(d,J=
8.0Hz,1H),6.77 and 6.33(2
s,2H),4.49 and 4.20(2s,2
H),3.48 and 3.38(t,J=7.0H
z,2H);IR(CHCl):1595,330
5,3030,3008,2963,2356,234
1,1663,1593,1515,1350c
−1;MS(70eV):m/z354(M+,1
1),255(64),181(100),148
(8),120(9),107(8),91(6),7
7(7),44(18);HRMS(70eV)cal
cd for C19H23N05(M+)345.1
576,found:345.1580.
<Synthesis 1-4> N-3 ', 4', 5'-Trimethyphenphen
ylmethyl-N- (4-hydroxyphen)
Synthesis of ylethyl) formamide (12b) Commercially available 3,4,5-trimethoxy under nitrogen stream
Benzaldehyde (10b) (2.0 g, 0.
01mol) in methanol (15ml) solution under ice-cooling, commercially available thymine hydrochloro
ride (1.74 g, 0.01 mol), molec
ultra sieves 4A (2.5 g), trie
thylamine (1.39 mL, 0.01 mol)
Was added and stirred at room temperature for 48 hours. After completion of the reaction, the insolubles were removed by filtration, and the filtrate was added with sodium hydroxide under ice-cooling.
orohydride (756mg, 0.02mol)
Was added and stirred at room temperature for 3 hours. After completion of the reaction, the reaction solution was poured into 1N-HCl for neutralization, and the solvent was distilled off under reduced pressure.
After the residue was extracted with ethyl acetate, the organic layer was washed with saturated saline and dried over anhydrous sodium sulfate.
After filtration, the solvent was distilled off under reduced pressure to obtain a crude product. The obtained crude product is subjected to silica gel column chromatography (el
uent; hexane: ethyl acetate
= 1: 1) to give 11b. 11b under nitrogen flow
(1.10 g) to formic acid (0.5 m
L), ethyl format (74 mL, 1 mo
l) was added and the mixture was refluxed at 70 ° C. for 10 hours. After completion of the reaction, insolubles were removed by filtration, and the crude product obtained by evaporating the solvent from the filtrate was subjected to silica gel column chromatography (eluent; hexane: ethyl acetate).
ate = 1: 1) and purified to 12b (1.475 g, 42).
% From 10b) was obtained. Colorless crystals; 1 H-NMR (CDCl 3 , 300 MHz)
δ: 8.24 and 7.83 (2s, 1H), 7.0
2 (d, J: 8.0 Hz, 1H), 6.90 (d, J =
8.0 Hz, 1 H), 6.77 and 6.33 (2
s, 2H), 4.49 and 4.20 (2s, 2
H), 3.48 and 3.38 (t, J = 7.0H)
z, 2H); IR (CHCl 3 ): 1595,330
5,3030,3008,2963,2356,234
1,1663,1593,1515,1350c
m -1 ; MS (70 eV): m / z 354 (M +, 1
1), 255 (64), 181 (100), 148
(8), 120 (9), 107 (8), 91 (6), 7
7 (7), 44 (18); HRMS (70 eV) cal
cd for C19H23N05 (M +) 345.1
576, found: 345.1580.

【0022】<合成1−5> N−3’,4’,5’−Trimethoxyphen
ylmethyl−N−(4−hydroxyphen
ylethyl)trifluoroacetoami
de(12c)の合成 窒素気流下、11b(110mg,0.35mmol)
のpyridine(1ml)溶液に氷冷下trifl
oroacetic acid anhydride
(0.127ml,0.9mmol)を加え、同温で1
時間撹拌した。反応終了後、反応液をethyl ac
etateで抽出した。抽出液を1N−HCl,飽和炭
酸水素ナトリウム水溶液,飽和食塩水で洗浄後、無水硫
酸ナトリウムで乾燥、濾過後、溶媒を留去し12c(9
6.5mg,95%)を得た。 無色結晶;H−NMR(CDCl,300MHz)
δ:7.02(d,J=8.0Hz,1H),6.90
(d,J=8.0Hz,1H),6.77 and
6,74(2d,J=8.0Hz,2H),6.77
and 6.33(2s,2H),4.49 and
4.20(2s,2H),3.88 and3.87
(2s,3H),3.84(s,3H),3.83 a
nd 3.81(2s,3H),3.48 and
3.38(2t,J=7.0Hz,2H),2.73
and 2.20(2t,J=7.0Hz,2H);I
R(CHCl):2937,2361,2341,1
688,1595,1508,1464,1234,1
198cm−1
<Synthesis 1-5> N-3 ', 4', 5'-Trimethyphenphen
ylmethyl-N- (4-hydroxyphen)
ylethyl) trifluoroacetoami
Synthesis of de (12c) 11b (110 mg, 0.35 mmol) under nitrogen stream
To a pyridine (1 ml) solution under ice cooling
oroacetic acid anhydride
(0.127 ml, 0.9 mmol) and add 1 at the same temperature.
Stirred for hours. After the completion of the reaction, the reaction solution was added to ethyl ac
Extracted with eate. The extract was washed with 1N-HCl, a saturated aqueous solution of sodium hydrogen carbonate, and saturated saline, dried over anhydrous sodium sulfate, filtered, and the solvent was distilled off to obtain 12c (9%).
(6.5 mg, 95%). Colorless crystals; 1 H-NMR (CDCl 3 , 300 MHz)
δ: 7.02 (d, J = 8.0 Hz, 1H), 6.90
(D, J = 8.0 Hz, 1H), 6.77 and
6,74 (2d, J = 8.0 Hz, 2H), 6.77
and 6.33 (2s, 2H), 4.49 and
4.20 (2s, 2H), 3.88 and 3.87
(2s, 3H), 3.84 (s, 3H), 3.83a
nd 3.81 (2s, 3H), 3.48 and
3.38 (2t, J = 7.0 Hz, 2H), 2.73
and 2.20 (2t, J = 7.0 Hz, 2H); I
R (CHCl 3 ): 2937,2361,2341,1
688, 1595, 1508, 1464, 1234, 1
198 cm -1 .

【0023】<合成1−6> N−3’,5’−Dibennzyloxy−4’−m
ethoxyphenylmethyl−N−(4−h
ydroxyphenylethyl)formami
de(12d)の合成 窒素気流下、11c(1.96g,4.2mmol)の
ethyl formate(40ml)溶液を65℃
にて1日還流した。反応終了後、溶媒を留去して得られ
た粗生成物をシリカゲルカラムクロマトグラフィー(c
hloroform:methanol=20:1)で
精製し12d(2.0g,97%)を得た。 無色結晶;H−NMR(CDCl,400MHz)
δ:8.13 and7.74(s,1H),7.43
−7.26(m,10H),6.92 and 6.7
1,6.82 and 6.74(AB type,
q,J=8.5Hz,4H),6.48 and 6.
33(s,2H,Ar−H),5.10(s,4H),
4.36 and 4.06(s,2H),3.900
and3.895(s,3H),3.30 and
3.14(t,J=6.9Hz,2H),2.61 a
nd 2.54(t,J=6.9Hz,2H).
<Synthesis 1-6> N-3 ', 5'-Dibennzyloxy-4'-m
ethoxyphenylmethyl-N- (4-h
hydroxyphenylethyl) formami
Synthesis of de (12d) A solution of 11c (1.96 g, 4.2 mmol) in ethyl formate (40 ml) was placed under a nitrogen stream at 65 ° C.
For 1 day. After completion of the reaction, the crude product obtained by evaporating the solvent was subjected to silica gel column chromatography (c
Purification by chloroform: methanol = 20: 1) gave 12d (2.0 g, 97%). Colorless crystals; 1 H-NMR (CDCl 3 , 400 MHz)
δ: 8.13 and 7.74 (s, 1H), 7.43
−7.26 (m, 10H), 6.92 and 6.7
1,6.82 and 6.74 (AB type,
q, J = 8.5 Hz, 4H), 6.48 and 6.
33 (s, 2H, Ar-H), 5.10 (s, 4H),
4.36 and 4.06 (s, 2H), 3.900
and 3.895 (s, 3H), 3.30 and
3.14 (t, J = 6.9 Hz, 2H), 2.61 a
nd 2.54 (t, J = 6.9 Hz, 2H).

【0024】<合成1−7> N−3’,5’−Dibenzyloxy−4’−me
thoxyphenylmethyl−N−(4−hy
droxyphenylethyl)trifluor
oacetoamide(12e)の合成 窒素気流下、11c(500mg,1.06mmol)
のpyridine(5ml)溶液にtifluoro
aceticanhydride(0.36ml,2.
56mmol)を滴下し、0℃にて10分間撹拌した。
反応終了後、反応液にmethanol(5ml)を滴
下し10分間撹拌した後、溶媒を留去して得られた粗生
成物をシリカゲルカラムクロマトグラフィー(ethy
l acetate:hexane=1:2)で精製
し、12e(543mg,91%)を得た。 H−NMR(CDCl,400MHz)δ:7.4
2−7.28(m,10H),6.92−6.88
(m,2H),6.76−6.72(m,2H),6.
43 and 6.29(s,1H),5.12 an
d 5.10(s,4H),4.45 and 4.1
6(s,2H),3.909 and 3.900
(s,3H),3.32−3.25(m,2H),2.
67−2.62(m,2H).
<Synthesis 1-7> N-3 ', 5'-Dibenzyloxy-4'-me
thoxyphenylmethyl-N- (4-hy
(doxyphenylethyl) trifluor
Synthesis of oacetoamide (12e) 11c (500 mg, 1.06 mmol) under nitrogen stream
In pyridine (5 ml) solution
aceticanhydride (0.36 ml, 2.
56 mmol) was added dropwise and the mixture was stirred at 0 ° C. for 10 minutes.
After completion of the reaction, methanol (5 ml) was added dropwise to the reaction solution, and the mixture was stirred for 10 minutes. The crude product obtained by distilling off the solvent was subjected to silica gel column chromatography (ethyl).
Purified by l acetate: hexane = 1: 2) to obtain 12e (543 mg, 91%). 1 H-NMR (CDCl 3 , 400 MHz) δ: 7.4
2-7.28 (m, 10H), 6.92-6.88
(M, 2H), 6.76-6.72 (m, 2H), 6.
43 and 6.29 (s, 1H), 5.12 an
d 5.10 (s, 4H), 4.45 and 4.1
6 (s, 2H), 3.909 and 3.900
(S, 3H), 3.32-3.25 (m, 2H), 2.
67-2.62 (m, 2H).

【0025】<合成1−8> 6,7,8−Trimethoxy−2−formyl
−1,2,3,4−tetrahydro−5H−
[2]benzazepine−5−spiro−1’
−cyclohexa−2’,5’−dien−4’−
one[13b]の合成 窒素気流下、12b(35mg,0.1mmol)の
2,2,2−trifluoroethanol(0.
5ml)溶液にphenyliodine(III)b
is(trifluoroacetate)(47m
g,0.11mmol)の2,2,2−trifluo
roethanol(0.5ml)溶液を滴下し、−4
0℃にて15分間撹拌した。反応終了後、溶媒を留去し
て得られた粗生成物をシリカゲルカラムクロマトグラフ
ィー(chloroform:methanol=1
5:1)で粗精製し、得られた粗生成物をethyl
acetateで結晶化し13b(32.8mg,96
%)を得た。 無色結晶;H−NMR(CDCl,400MHz)
δ:8.24 and8.19(s,1H),7.01
and 6.96(eachd,J=10.1Hz,
2H),6.62 and 6.47(s,1H),
6.30(d,J=10.1Hz,2H),4.70
and 4.63(s,2H),3.884 and
3.876(s,3H),3.78 and 3.76
(s,3H),3.75−3.66(m,2H),3.
63 and 3.61(s,3H),2.34−2.
27(m,2H).
<Synthesis 1-8> 6,7,8-Trimethyoxy-2-formyl
-1,2,3,4-tetrahydro-5H-
[2] benzazepine-5-spiro-1 ′
-Cyclohexa-2 ', 5'-dien-4'-
Synthesis of one [13b] Under a nitrogen stream, 12b (35 mg, 0.1 mmol) of 2,2,2-trifluoroethanol (0.
Phenyliodine (III) b
is (trifluoroacetate) (47m
g, 0.11 mmol) of 2,2,2-trifluo
ethanol (0.5 ml) solution was added dropwise.
Stirred at 0 ° C. for 15 minutes. After completion of the reaction, the crude product obtained by evaporating the solvent was subjected to silica gel column chromatography (chloroform: methanol = 1).
5: 1), and the obtained crude product is ethyl.
Crystallized from acetate to give 13b (32.8 mg, 96
%). Colorless crystals; 1 H-NMR (CDCl 3 , 400 MHz)
δ: 8.24 and 8.19 (s, 1H), 7.01
and 6.96 (eachd, J = 10.1 Hz,
2H), 6.62 and 6.47 (s, 1H),
6.30 (d, J = 10.1 Hz, 2H), 4.70
and 4.63 (s, 2H), 3.884 and
3.876 (s, 3H), 3.78 and 3.76
(S, 3H), 3.75-3.66 (m, 2H), 3.
63 and 3.61 (s, 3H), 2.34-2.
27 (m, 2H).

【0026】<合成1−9> 6,7,8−Trimethoxy−2−triflu
oroacetyl−1,2,3,4−tetrahy
dro−5H−[2]benzazepine−5−s
piro−1’−cyclohexa−2’,5’−d
ien−4’−one[13c]の合成 窒素気流下、12c(0.186mg,0.45mmo
l)の2,2,2−trifluoroethanol
(3ml)溶液に−40℃下、phenyliodin
e(III)bis(trifluoroacetat
e)(0.213g,0.495mmol)の2,2,
2−trifluoroethanol(5ml)溶液
を滴下し、同温で2時間撹拌した。反応終了後、溶媒を
留去して得られた粗生成物をシリカゲルカラムクロマト
グラフィー(eluent;hexane:ethyl
acetate=1:1)で精製し13c(0.13
9g,75%)を得た。 無色結晶;H−NMR(CDCl,300MHz)
d:7.98 and6.94(2d,J=10.0H
z,2H),6.63 and 6.45(2s,1
H),6.32(d,J=10.0Hz,2H),4.
82 and4.78(2s,2H),3.89 an
d 3.88(2s,3H),3.87−3.84
(m,2H),3.79,3.77,3.64 and
3.63(4s,6H),2.34(t,J=6.0
Hz,2H);IR(CHCl):3030,300
5,2941,2359,2341,1690,166
1,1622,1595,1464,1333,123
6,1198cm−1;MS(70eV):m/z41
1(M+,58),380(12),285(10
0),271(45),254(29),181(1
5);HRMS(70eV)calcd for C2
0H20F3N05(M+)411.1293,fou
nd:411.1285.
<Synthesis 1-9> 6,7,8-Trimethyoxy-2-triflu
oroacetyl-1, 2,3,4-tetrahy
dro-5H- [2] benzazepine-5-s
piro-1'-cyclohexa-2 ', 5'-d
Synthesis of ie-4′-one [13c] 12c (0.186 mg, 0.45 mmol) under a nitrogen stream
l) 2,2,2-trifluoroethanol
(3 ml) solution at -40 ° C under phenyliodin
e (III) bis (trifluoroacetat
e) (0.213 g, 0.495 mmol) of 2,2
2-Trifluoroethanol (5 ml) solution was added dropwise, and the mixture was stirred at the same temperature for 2 hours. After completion of the reaction, the crude product obtained by distilling off the solvent was subjected to silica gel column chromatography (eluent; hexane: ethyl).
acetate = 1: 1) and purified to 13c (0.13
9g, 75%). Colorless crystals; 1 H-NMR (CDCl 3 , 300 MHz)
d: 7.98 and 6.94 (2d, J = 10.0H
z, 2H), 6.63 and 6.45 (2s, 1
H), 6.32 (d, J = 10.0 Hz, 2H), 4.
82 and 4.78 (2s, 2H), 3.89 an
d 3.88 (2s, 3H), 3.87-3.84
(M, 2H), 3.79, 3.77, 3.64 and
3.63 (4s, 6H), 2.34 (t, J = 6.0)
Hz, 2H); IR (CHCl 3 ): 3030, 300
5,2941,359,2341,1690,166
1,1622, 1595, 1464, 1333, 123
6,1198 cm -1 ; MS (70 eV): m / z 41
1 (M +, 58), 380 (12), 285 (10
0), 271 (45), 254 (29), 181 (1
5); HRMS (70 eV) calcd for C2
0H20F3N05 (M +) 411.1293, fou
nd: 411.1285.

【0027】<合成1−10> 6,8−Dibennzyloxy−7−methox
y−2−formyl−1,2,3,4−tetrah
ydro−5H−[2]benzazepine−5−
spiro−1’−cyclohexa−2’,5’−
dien−4’−one[13d]の合成 窒素気流下、12d(2.0g,4.0mmol)の
2,2,2−trifluoroethanol(10
0ml)溶液にphenyliodine(III)b
is(trifluoroacetate)(1.9
g,4.4mmol)の2,2,2−trifluor
oethanol(10ml)溶液を滴下し、−40℃
にて1時間撹拌した。反応終了後、溶媒を留去して得ら
れた粗生成物をethyl acetateで結晶化し
13d(1.29g,65%)を得た。母液をシリカゲ
ルカラムクロマトグラフィー(chloroform:
methanol=20:1)で粗精製し、得られた粗
生成物をethyl acetateで結晶化し13d
(341.5mg,17%)を得た。 無色結晶;H−NMR(CDCl,400MHz)
δ:8.21 and8.19(s,1H),7.47
−7.22(m,10H),7.05 and 6.1
4,6.98 and 6.14(AB type,
q,J=10.2Hz,4H),6.76 and
6.57(s,1H,Ar−H),5.15 and
5.14(s,2H),4.88 and 4.84
(s,2H),4.69 and 4.60(s,2
H),3.75 and 3.74(s,3H),3.
71 and 3.65(t,J=6.2Hz,2
H),2.29 and 2.26(t,J=6.2H
z,2H).
<Synthesis 1-10> 6,8-Dibenzyloxy-7-methox
y-2-formyl-1,2,3,4-tetrah
ydro-5H- [2] benzazepine-5-
spiro-1'-cyclohexa-2 ', 5'-
Synthesis of dien-4′-one [13d] Under nitrogen stream, 12d (2.0 g, 4.0 mmol) of 2,2,2-trifluoroethanol (10
0 ml) solution to phenyliodine (III) b
is (trifluoroacetate) (1.9
g, 4.4 mmol) of 2,2,2-trifluor
oethanol (10 ml) solution was added dropwise at -40 ° C.
For 1 hour. After completion of the reaction, the crude product obtained by distilling off the solvent was crystallized from ethyl acetate to obtain 13d (1.29 g, 65%). The mother liquor was subjected to silica gel column chromatography (chloroform:
The resulting crude product was crystallized from ethyl acetate to obtain 13d.
(341.5 mg, 17%). Colorless crystals; 1 H-NMR (CDCl 3 , 400 MHz)
δ: 8.21 and 8.19 (s, 1H), 7.47
-7.22 (m, 10H), 7.05 and 6.1
4, 6.98 and 6.14 (AB type,
q, J = 10.2 Hz, 4H), 6.76 and
6.57 (s, 1H, Ar-H), 5.15 and
5.14 (s, 2H), 4.88 and 4.84
(S, 2H), 4.69 and 4.60 (s, 2
H), 3.75 and 3.74 (s, 3H), 3.
71 and 3.65 (t, J = 6.2 Hz, 2
H), 2.29 and 2.26 (t, J = 6.2H)
z, 2H).

【0028】<合成1−11> 6,8−Dibennzyloxy−7−methox
y−2−trifluoroacetyl−1,2,
3,4−tetrahydro−5H−[2]benz
azepine−5−spiro−1’−cycloh
exa−2’,5’−dien−4’−one[13
e]の合成 窒素気流下、12e(1.8g,3.2mmol)の
2,2,2−trifluoroethanol(15
ml)溶液にphenyliodine(III)bi
s(trifluoroacetate)(1.7g,
3.8mmol)の2,2,2−trifluoroe
thanol(15ml)溶液を滴下し、−40℃にて
1時間撹拌した。反応終了後、溶媒を減圧留去して得ら
れた粗生成物をシリカゲルカラムクロマトグラフィー
(ethylacetate:hexane=1:1
0)で精製し、13e(960.7mg,53%)を得
た。 1H−NMR(CDCl3,400MHz)δ:7.4
7−7.22(m,10H),7.01 and 6.
94(each d,J=10.1Hz,2H),6.
77 and 6.55(s,1H),6.14(d,
J=10.1Hz,2H),5.14(s,2H),
4.91 and 4.89(s,2H),4.80
and 4.74(s,2H),3.88−3.80
(m,2H),3.76 and 3.75(each
s,3H),2.32−2.04(m,2H).
<Synthesis 1-11> 6,8-Dibenzyloxy-7-methox
y-2-trifluoroacetyl-1,2,2
3,4-tetrahydro-5H- [2] benz
azpine-5-spiro-1'-cycloh
exe-2 ′, 5′-dien-4′-one [13
Synthesis of 12e (1.8 g, 3.2 mmol) of 2,2,2-trifluoroethanol (15
phenyliodine (III) bi
s (trifluoroacetate) (1.7 g,
3.8 mmol) of 2,2,2-trifluoroe
Then, a toluene (15 ml) solution was added dropwise, and the mixture was stirred at -40 ° C for 1 hour. After completion of the reaction, the crude product obtained by evaporating the solvent under reduced pressure was subjected to silica gel column chromatography (ethyl acetate: hexane = 1: 1).
Purification by 0) afforded 13e (960.7 mg, 53%). 1H-NMR (CDCl3, 400 MHz) δ: 7.4
7-7.22 (m, 10H), 7.01 and 6.
5. 94 (each d, J = 10.1 Hz, 2H);
77 and 6.55 (s, 1H), 6.14 (d,
J = 10.1 Hz, 2H), 5.14 (s, 2H),
4.91 and 4.89 (s, 2H), 4.80
and 4.74 (s, 2H), 3.88-3.80
(M, 2H), 3.76 and 3.75 (each
s, 3H), 2.32-2.04 (m, 2H).

【0029】<合成1−12> (±)−3−Hydroxy−N−trifluoro
acetyl−N−nornarwedine(14
a)の合成 窒素気流下、12a(198mg,0.5mmol)の
2,2,2−trifluoroethanol(4m
l)溶液に撹拌下−15〜−20℃でphenylio
dine(III)bis(trifluoroace
tate)(322mg,0.75mmol)の2,
2,2−trifluoroethanol(1ml)
溶液を滴下し、同温にて10分間撹拌した。反応終了
後、溶媒を留去して得られた粗生成物にcrushed
ice及び5%炭酸水素ナトリウム水溶液を加えて撹
拌し、析出した沈殿物を濾取し、風乾し褐色の粉末21
0mgを得た。その粉末をシリカゲルカラムクロマトグ
ラフィーで精製し、14a(23mg,12%)を得
た。 H−NMR(CDCl,400MHz)δ:6.8
5 and 6.09,6.79 and 6.07
(AB type,q,J=10.3Hz,4H),
6.56 and 6.40(s,1H,Ar−H),
5.21 and4.09,4.81 and 4.5
0(AB type,q,J=16.0Hz,2H),
4.79,4.37−4.33,3.73−3.66,
3.33(m,2H),4.73(brs,1H),
3.97 and 3.95(s,3H),3.15−
3.11,2.81−2.74(m,2H),2.23
−2.08(m,2H). 窒素気流下、13e(284mg,0.5mmol)の
dimethyl sulfide(1ml)溶液にt
rifluoroacetic acid(2ml)を
加え、室温にて5日間撹拌した。反応終了後、溶媒を減
圧留去して、得られた粗生成物をシリカゲルカラムクロ
マトグラフィー(ethylacetate:hexa
ne=1:2)で精製し、14a(163mg,85
%)を得た。
<Synthesis 1-12> (±) -3-Hydroxy-N-trifluoro
acetyl-N-nornarwedine (14
Synthesis of a) 12a (198 mg, 0.5 mmol) of 2,2,2-trifluoroethanol (4 m
l) The solution was stirred at -15 to -20 ° C with phenylio.
dine (III) bis (trifluoroace)
date) (322 mg, 0.75 mmol) of 2,
2,2-trifluoroethanol (1 ml)
The solution was added dropwise and stirred at the same temperature for 10 minutes. After completion of the reaction, the crude product obtained by evaporating the solvent was crushed.
ice and a 5% aqueous solution of sodium hydrogencarbonate were added thereto, followed by stirring.
0 mg was obtained. The powder was purified by silica gel column chromatography to obtain 14a (23 mg, 12%). 1 H-NMR (CDCl 3 , 400 MHz) δ: 6.8
5 and 6.09, 6.79 and 6.07
(AB type, q, J = 10.3 Hz, 4H),
6.56 and 6.40 (s, 1H, Ar-H),
5.21 and 4.09, 4.81 and 4.5
0 (AB type, q, J = 16.0 Hz, 2H),
4.79, 4.37-4.33, 3.73-3.66,
3.33 (m, 2H), 4.73 (brs, 1H),
3.97 and 3.95 (s, 3H), 3.15-
3.11, 2.81-2.74 (m, 2H), 2.23
-2.08 (m, 2H). Under a nitrogen stream, a solution of 13e (284 mg, 0.5 mmol) in dimethyl sulfide (1 ml) was added to the solution.
rifluoroacetic acid (2 ml) was added, and the mixture was stirred at room temperature for 5 days. After completion of the reaction, the solvent was distilled off under reduced pressure, and the obtained crude product was subjected to silica gel column chromatography (ethyl acetate: hexa).
ne = 1: 2) to give 14a (163 mg, 85
%).

【0030】<合成1−13> (±)−3−Hydroxy=N−formyl−N−
nornarwedine(14b)の合成 窒素気流下、13d(1.0g,2.0mmol)のd
ichloromethane(10ml)溶液にbo
rontrichloride(6.1ml,1M i
n dichloromethane,6.1mmo
l)を加え、−78℃にて20時間撹拌した。反応終了
後、反応液に氷水を加え、30分撹拌し、chloro
form抽出した。抽出液を無水硫酸ナトリウムで乾
燥、濾過後、溶媒を留去して得られた粗生成物をeth
ylacetateで結晶化し14b(605.3m
g,95%)を得た。 無色結晶;H−NMR(CDCl,400MHz)
δ:8.18 and8.15(s,1H),6.87
and 6.07,6.83 and 6.06(A
B type,q,J=10.3Hz,4H),6.5
4 and6.39(s,1H,Ar−H),5.18
−5.14,4.63,4.04−4.00(m,2
H),4.71−4.69(m,1H),4.65−
4.61,4.02−3.95,3.69−3.62,
3.27−3.20(m,2H),3.95 and
3.92(s,3H),3.15−3.09,2.81
−2.74(m,2H),2.24−1.94(m,2
H). 窒素気流下、13d(35mg,0.07mmol)の
dimethyl sulfide(0.5ml)溶液
にtrifluoroacetic acid(1m
l)を加え、室温にて4日間撹拌した。反応終了後、溶
媒を減圧留去して、得られた粗生成物をシリカゲルカラ
ムクロマトグラフィー(ethylacetate o
nly)で精製し、14b(17.9mg,81%)を
得た。
<Synthesis 1-13> (±) -3-Hydroxy = N-formyl-N-
Synthesis of nornarwedine (14b) 13d (1.0 g, 2.0 mmol) of d under a nitrogen stream
Ichlomethane (10ml) solution with bo
rontrichloride (6.1 ml, 1 Mi
n dichloromethane, 6.1mmo
l) was added and the mixture was stirred at -78 ° C for 20 hours. After completion of the reaction, ice water was added to the reaction solution, and the mixture was stirred for 30 minutes.
form was extracted. The extract was dried over anhydrous sodium sulfate, filtered, and the solvent was distilled off.
It is crystallized with ylacetate and 14b (605.3m
g, 95%). Colorless crystals; 1 H-NMR (CDCl 3 , 400 MHz)
δ: 8.18 and 8.15 (s, 1H), 6.87
and 6.07, 6.83 and 6.06 (A
B type, q, J = 10.3 Hz, 4H), 6.5
4 and 6.39 (s, 1H, Ar-H), 5.18
−5.14, 4.63, 4.04−4.00 (m, 2
H), 4.71-4.69 (m, 1H), 4.65-
4.61, 4.02-3.95, 3.69-3.62,
3.27-3.20 (m, 2H), 3.95 and
3.92 (s, 3H), 3.15-3.09, 2.81
-2.74 (m, 2H), 2.24-1.94 (m, 2
H). Trifluoroacetic acid (1 m) was added to a 13 d (35 mg, 0.07 mmol) solution of dimethyl sulfide (0.5 ml) under a nitrogen stream.
l) was added and the mixture was stirred at room temperature for 4 days. After completion of the reaction, the solvent was distilled off under reduced pressure, and the resulting crude product was subjected to silica gel column chromatography (ethyl acetate o).
nly) to give 14b (17.9 mg, 81%).

【0031】<合成1−14> (±)−3−Trifluoromethanesuf
onyloxy−N−trifluoroacetyl
−N−nornarwedine(15)の合成 窒素気流下、14b(200mg,0.63mmol)
のpyridine(4ml)溶液にtrifluor
omethanesulfonic anhydrid
e(0.26ml,1.52mmol)を滴下し、0℃
にて1時間撹拌した。反応終了後、反応液にmetha
nol(4ml)を滴下し10分撹拌した後、溶媒を留
去して得られた粗生成物をシリカゲルカラムクロマトグ
ラフィー(chloroform:methanol=
5:1)で粗精製し、得られた粗生成物をethyl
acetateで結晶化し15(278.3mg,98
%)を得た。 H−NMR(CDCl,400MHz)δ:8.1
9 and 8.16(s,1H),6.89−6.8
04(m,1H),6.798−6.67(s,1
H),6.17−6.12(m,1H),5.22−
5.18,4.67−4.61,4.07−4.01,
3.73−3.70,3.28(m,4H),4.00
and 3.99(s,3H),3.19−3.1
7,3.14−3.12,2.83−2.76(m,2
H),2.34−2.00(m,2H).
<Synthesis 1-14> (±) -3-Trifluoromethanesuf
onyloxy-N-trifluoroacetyl
Synthesis of -N-nornarwedine (15) 14b (200 mg, 0.63 mmol) under a nitrogen stream
In a pyridine (4 ml) solution of
omethanesulfonic anhydrid
e (0.26 ml, 1.52 mmol) was added dropwise at 0 ° C.
For 1 hour. After the reaction is completed, add
Nol (4 ml) was added dropwise, and the mixture was stirred for 10 minutes. The solvent was distilled off, and the resulting crude product was subjected to silica gel column chromatography (chloroform: methanol =
5: 1), and the obtained crude product is ethyl.
Acetate crystallized 15 (278.3 mg, 98
%). 1 H-NMR (CDCl 3 , 400 MHz) δ: 8.1
9 and 8.16 (s, 1H), 6.89-6.8
04 (m, 1H), 6.798-6.67 (s, 1
H), 6.17-6.12 (m, 1H), 5.22-
5.18, 4.67-4.61, 4.07-4.01,
3.73-3.70, 3.28 (m, 4H), 4.00
and 3.99 (s, 3H), 3.19-3.1
7, 3.14-3.12, 2.83-2.76 (m, 2
H), 2.34-2.00 (m, 2H).

【0032】<合成1−15> (±)−N−formyl−N−nornarwedi
ne(16)の合成 窒素気流下、15(30mg,0.067mmol),
triethylamine(20mg,0.2mmo
l),palladiumacetate(0.29m
g,0.0013mmol),triphenylph
osphine(0.7mg,0.0027mmol)
のN,N−dimethylformamide(0.
5ml)溶液にformic acid(6.17m
g,0.134mmol)を滴下し、60℃にて3時間
撹拌した。反応終了後、反応液に飽和食塩水を加え、e
ther抽出した。抽出液を飽和食塩水で洗浄し、無水
硫酸ナトリウムで乾燥、濾過後、溶媒を留去して得られ
た粗生成物 (88.8mg)をシリカゲルカラムクロ
マトグラフィー(chloroform:methan
ol=15:1)で精製し16(19.4mg,97
%)を得た。 無色結晶;H−NMR(CDCl,400MHz)
δ:8.18 and8.15(s,1H),6.90
and 6.10,6.85 and 6.09(A
B type,q,J=10.6Hz,2H),6.8
96−6.88,6.74−6.72,6.736
(m,2H,Ar−H),5.29−5.25,4.6
1−4.50,4.07−4.04(m,2H),4.
73−4.70(m,1H),4.68−4.65,
4.03−3.99,3.73−3.66,3.28−
3.21(m,2H),3.86 and 3.85
(s,3H),3.23−3.17,2.80−2.7
3(m,2H),2.12−1.98(m,2H).
<Synthesis 1-15> (±) -N-formyl-N-nornarwedi
Synthesis of ne (16) 15 (30 mg, 0.067 mmol),
triethylamine (20mg, 0.2mmo
l), palladium acetate (0.29m
g, 0.0013 mmol), triphenylph
ospine (0.7mg, 0.0027mmol)
N, N-dimethylformamide (0.
5 ml) solution to formic acid (6.17 m)
g, 0.134 mmol) was added dropwise and stirred at 60 ° C. for 3 hours. After completion of the reaction, a saturated saline solution was added to the reaction solution, and e was added.
Ther was extracted. The extract was washed with saturated saline, dried over anhydrous sodium sulfate, filtered, and the solvent was distilled off. A crude product (88.8 mg) obtained was subjected to silica gel column chromatography (chloroform: methan).
ol = 15: 1) and purified to 16 (19.4 mg, 97
%). Colorless crystals; 1 H-NMR (CDCl 3 , 400 MHz)
δ: 8.18 and 8.15 (s, 1H), 6.90
and 6.10, 6.85 and 6.09 (A
B type, q, J = 10.6 Hz, 2H), 6.8
96-6.88, 6.74-6.72, 6.736
(M, 2H, Ar-H), 5.29-5.25, 4.6
1-4.50, 4.07-4.04 (m, 2H), 4.
73-4.70 (m, 1H), 4.68-4.65,
4.03-3.99, 3.73-3.66, 3.28-
3.21 (m, 2H), 3.86 and 3.85
(S, 3H), 3.23-3.17, 2.80-2.7.
3 (m, 2H), 2.12-1.98 (m, 2H).

【0033】<合成1−16> (±)−Galanthamineの合成 窒素気流下、16(15mg,0.05mmol)のt
etrahydrofuran(1ml)溶液を−78
℃にて20分撹拌した。その溶液にL−Selectr
ide(0.21ml,1M in tetrahyd
rofuran,0.21mmol)を滴下し、−78
℃にて3時間撹拌した。反応終了後、反応液に、lit
hium aluminum hydride(4.6
mg,0.12mmol)のtetrahydrofu
ran(1ml)溶液を滴下し、0℃にて1日撹拌し
た。反応終了後、反応液に水と10%水酸化ナトリウム
水溶液を加えた。その混合液を濾過後、溶媒を留去し得
られた粗生成物をシリカゲルカラムクロマトグラフィー
(chloroform:methanol=5:1)
で精製しgalanthamine(6.5mg,45
%)を得た。 白色結晶;H−NMR(CDCl,400MHz)
δ:6.68(d,J=8.1Hz,1H,H−8),
6.64(d,J=8.2Hz,1H,H−7),6.
06(d,J=10.3Hz,1H,H−4a),6.
02(dd,J=10.5Hz,4.1Hz,1H,H
−4),4.62(brs,1H,H−1),4.15
(t,J=4.8Hz,1H,H−3),4.14
(d,J=15.4Hz,1H,H−6),3.84
(s,3H,OMe),3.73(d,J=14.7H
z,1H,H−6),3.32(t,J=13.0H
z,1H,H−12),3.09(d,J=14.5H
z,1H,H−12),2.72−2.67(m,1
H,H−2),2.43(s,3H,NMe)2.31
−2.06(m,1H,H−2),2.04−1.89
(m,1H,H−11),1.70−1.60(m,1
H,H−11).
<Synthesis 1-16> Synthesis of (±) -Galantamine 16 (15 mg, 0.05 mmol) of t under nitrogen stream
Add the Etrahydrofuran (1 ml) solution to -78
Stirred at ° C for 20 minutes. L-Selectr is added to the solution.
ide (0.21 ml, 1M in tetrahyd
rofuran, 0.21 mmol) was added dropwise.
Stirred at C for 3 hours. After the reaction is completed, lit
high aluminum hydride (4.6
mg, 0.12 mmol) of tetrahydrofu
A ran (1 ml) solution was added dropwise, and the mixture was stirred at 0 ° C. for 1 day. After completion of the reaction, water and a 10% aqueous sodium hydroxide solution were added to the reaction solution. After the mixture was filtered, the solvent was distilled off, and the resulting crude product was subjected to silica gel column chromatography (chloroform: methanol = 5: 1).
And purified by galantamine (6.5 mg, 45
%). White crystal; 1 H-NMR (CDCl 3 , 400 MHz)
δ: 6.68 (d, J = 8.1 Hz, 1H, H-8),
6.64 (d, J = 8.2 Hz, 1H, H-7);
06 (d, J = 10.3 Hz, 1H, H-4a);
02 (dd, J = 10.5 Hz, 4.1 Hz, 1H, H
-4), 4.62 (brs, 1H, H-1), 4.15
(T, J = 4.8 Hz, 1H, H-3), 4.14
(D, J = 15.4 Hz, 1H, H-6), 3.84
(S, 3H, OMe), 3.73 (d, J = 14.7H)
z, 1H, H-6), 3.32 (t, J = 13.0H)
z, 1H, H-12), 3.09 (d, J = 14.5H)
z, 1H, H-12), 2.72-2.67 (m, 1
H, H-2), 2.43 (s, 3H, NMe) 2.31.
-2.06 (m, 1H, H-2), 2.04-1.89
(M, 1H, H-11), 1.70-1.60 (m, 1
H, H-11).

【0034】<合成1−17> (±)−Narwedineの合成 窒素気流下、16(20mg,0.067mmol)の
benzene溶液にethylene glycol
とpyridiniump−toluenesulfo
nateを加え、110℃にて2日間還流した。反応終
了後、反応液を飽和炭酸水素ナトリウム水溶液で洗浄
し、溶媒を留去し得られた粗生成物をchlorofo
rm抽出した。抽出液を無水硫酸ナトリウムで乾燥、濾
過後、溶媒を留去して得られた粗生成物(45.4m
g)をシリカゲルカラムクロマトグラフィー(chlo
roform:methanol=10:1)で精製し
17を得た(21.2mg,92%)。窒素気流下、1
7(13.2mg,0.05mmol)のtetrah
ydrofuran (0.5ml)溶液に氷冷下li
thium aluminum hydride(4.
4mg,0.12mmol)のtetrahydrof
uran(1ml)溶液を滴下し、室温にて19時間撹
拌した。反応終了後、反応液に飽和硫酸ナトリウム水溶
液を加え、無水硫酸ナトリウムで乾燥した。その混合液
を濾過後、溶媒を留去し得られた粗生成物を(20.7
mg)にtetrahydrofuran(0.5m
l)を加え、撹拌下1N−HClを滴下し、室温にて2
2時間撹拌した。反応終了後、反応液に飽和炭酸水素ナ
トリウム水溶液を滴下し、クロロホルム抽出した。抽出
液を無水硫酸ナトリウムで乾燥、濾過後、溶媒を留去し
て得られた粗生成物(18.0mg)をシカゲルカラム
クロマトグラフィー(chloroform:meth
anol=10:1)で精製しnarwedine
(5.9mg,54%)を得た。これらの反応プロセス
を図5に示す。 白色結晶;H−NMR(CDCl,400MHz)
δ:6.95(d,J=10.3Hz,1H,en
e),6.70(d,=8.2Hz,1H,Ar−
H),6.66(d,J=8.2Hz,1H,Ar−
H),6.05(d,J=10.4,1H,en
e),.75−4.73(m,1H),4.10(d,
J=15.4Hz,1H),3.85(s,3H,OM
e),3.75(d,J=15.4Hz,H),3.1
9(m,3H),2.75(dd,J=17.9Hz,
3.8Hz,1H),2.45(s,3H,NMe),
2.28(dt,J=13.2Hz,3.5Hz,1
H),1.89−1.84(m,1H).
<Synthesis 1-17> Synthesis of (±) -Narwedine Ethylene glycol was added to 16 (20 mg, 0.067 mmol) of benzene solution under a nitrogen stream.
And pyridiniump-toluenesulfo
The mixture was refluxed at 110 ° C. for 2 days. After the completion of the reaction, the reaction solution was washed with a saturated aqueous solution of sodium hydrogen carbonate, and the solvent was distilled off.
rm extracted. After the extract was dried over anhydrous sodium sulfate and filtered, the solvent was distilled off to obtain a crude product (45.4 m
g) by silica gel column chromatography (chlo)
Roform: methanol = 10: 1) to give 17 (21.2 mg, 92%). Under nitrogen flow, 1
7 (13.2 mg, 0.05 mmol) in tetrah
ydrofuran (0.5ml) solution under ice-cooling
thium aluminum hydride (4.
4mg, 0.12mmol) tetrahydrof
Uran (1 ml) solution was added dropwise and stirred at room temperature for 19 hours. After completion of the reaction, a saturated aqueous solution of sodium sulfate was added to the reaction solution, and the mixture was dried over anhydrous sodium sulfate. After the mixture was filtered, the solvent was distilled off to obtain a crude product (20.7%).
mg) in tetrahydrofuran (0.5m
l) was added thereto, and 1N-HCl was added dropwise with stirring.
Stir for 2 hours. After completion of the reaction, a saturated aqueous solution of sodium hydrogen carbonate was added dropwise to the reaction solution, followed by extraction with chloroform. After the extract was dried over anhydrous sodium sulfate and filtered, the solvent was distilled off, and the resulting crude product (18.0 mg) was subjected to silica gel column chromatography (chloroform: meth).
nanol = 10: 1)
(5.9 mg, 54%). These reaction processes are shown in FIG. White crystal; 1 H-NMR (CDCl 3 , 400 MHz)
δ: 6.95 (d, J = 10.3 Hz, 1H, en
e), 6.70 (d, = 8.2 Hz, 1H, Ar-
H), 6.66 (d, J = 8.2 Hz, 1H, Ar-
H), 6.05 (d, J = 10.4, 1H, en
e),. 75-4.73 (m, 1H), 4.10 (d,
J = 15.4 Hz, 1H), 3.85 (s, 3H, OM)
e), 3.75 (d, J = 15.4 Hz, H), 3.1.
9 (m, 3H), 2.75 (dd, J = 17.9 Hz,
3.8Hz, 1H), 2.45 (s, 3H, NMe),
2.28 (dt, J = 13.2 Hz, 3.5 Hz, 1
H), 1.89-1.84 (m, 1H).

【第1表】カップリング反応から得られる各種カップリ
ング体の反応収率
Table 1 Reaction yields of various coupling products obtained from the coupling reaction

【第1表】 [Table 1]

【図面の簡単な説明】[Brief description of the drawings]

【図1】 本発明により高収率で合成される代表的ガラ
ンタミン型アルカロイド
FIG. 1 A representative galantamine-type alkaloid synthesized in high yield according to the present invention.

【図2】 没食子酸メチルエステルから各種カップリン
グ反応基質を合成する反応プロセス
Fig. 2 Reaction process for synthesizing various coupling reaction substrates from gallic acid methyl ester

【図3】 カップリング反応プロセスFig. 3 Coupling reaction process

【図4】 ガランタミン型骨格生成反応プロセスFIG. 4 Galantamine-type skeleton formation reaction process

【図5】 ガランタミン及びナルウエジンの生成反応プ
ロセス
FIG. 5: Galantamine and nalwezin formation reaction process

Claims (13)

【特許請求の範囲】[Claims] 【請求項1】 一般式 【化1】 (式中のRは炭化水素基または酸素原子が含まれる炭
化水素基もしくは有機ケイ素基の保護基を、Rはアミ
ド結合からなる保護基を示す)で表されるフェノール誘
導体を次式PhI(OCOCFで表されるフェニ
ルヨージン(III)ビス(トリフルオロアセタート)
等の超原子価ヨー素(III)試薬と反応させて、一般
式 【化2】 の化合物を製造することを特徴とする分子内カップリン
グ体の製造方法。
1. A compound of the general formula (Wherein R 1 represents a protecting group for a hydrocarbon group or a hydrocarbon group containing an oxygen atom or an organosilicon group, and R 2 represents a protecting group comprising an amide bond). Phenyliodine (III) bis (trifluoroacetate) represented by (OCOCF 3 ) 2
By reacting with a hypervalent iodine (III) reagent such as A method for producing an intramolecularly coupled product, which comprises producing the compound of formula (I).
【請求項2】 超原子価ヨー素(III)試薬が、式P
hI(OCOCFで表されるフェニルヨージン
(III)ビス(トリフルオロアセタート)である請求
項1の製造方法。
2. The hypervalent iodine (III) reagent has the formula P
hI (OCOCF 3) phenyl iodide emissions represented by 2 (III) The method of manufacturing according to claim 1 which is bis (trifluoroacetate).
【請求項3】 反応を、フルオロ置換アルコール類を溶
媒として行う請求項1または2の製造方法。
3. The method according to claim 1, wherein the reaction is carried out using a fluoro-substituted alcohol as a solvent.
【請求項4】 Rの保護基が、ベンジル基、アリル
基、tert−ブチル基、ベンジルオキシメチル基、メ
トキシメチル基、メトキシエチル基、メトキシベンジル
基、もしくは次式RSi−、(R、R
よびRは炭化水素を示す)、で表される請求項1また
は2の製造方法。
4. The protecting group for R 1 is a benzyl group, an allyl group, a tert-butyl group, a benzyloxymethyl group, a methoxymethyl group, a methoxyethyl group, a methoxybenzyl group, or a compound represented by the following formula: R 3 R 4 R 5 Si -, (R 3, R 4 and R 5 is a hydrocarbon), in the manufacturing method according to claim 1 or 2 represented.
【請求項5】 Rのアミド結合からなる保護基が次式
−CO−(Rは水素原子またはフルオロ置換炭化
水素を示す)で表される請求項1または2の製造方法。
5. The method according to claim 1, wherein the protecting group comprising an amide bond of R 2 is represented by the following formula: R 6 —CO— (R 6 represents a hydrogen atom or a fluoro-substituted hydrocarbon).
【請求項6】 一般式 【化3】 (式中のRは、水酸基、置換基を有していてもよいア
ルコキシ基、アシルオキシ基またはアシル基もしくは環
構成の炭素原子とともにカルボニル基を形成する酸素原
子を示し、Rは、水素原子または置換基を有していて
もよい炭化水素基を示す)のいずれかで表されるガラン
タミン(galanthamine)型ヒガンバナアル
カロイド(Amaryllidaceaealkalo
id)類の製造方法であって、請求項1ないし5のいず
れかの分子内カップリング体の製造工程を含むことを特
徴とするガランタミン型ヒガンバナアルカロイド類の製
造方法。
6. A compound of the general formula (Wherein R 7 represents a hydroxyl group, an alkoxy group which may have a substituent, an acyloxy group or an oxygen atom which forms a carbonyl group together with an acyl group or a carbon atom constituting a ring, and R 8 represents a hydrogen atom Or a hydrocarbon group which may have a substituent) or a galantamine-type amaryllidaceae alkaloid (Amaryllidaceaealkalo)
A method for producing galantamine-type amaryllidaceae alkaloids, which comprises a process for producing the intramolecularly coupled product according to any one of claims 1 to 5, which is a method for producing id).
【請求項7】 一般式 【化4】 (式中のRは、炭化水素基または酸素原子が含まれる炭
化水素基もしくは有機ケイ素基の保護基を示す)で表さ
れるフェノール誘導体を、フェニルヨージン(III)
ビス(トリフルオロアセタート)と反応させて分子内カ
ップリング体を生成させる請求項6のガランタミン型ヒ
ガンバナアルカロイド類の製造方法。
7. A compound of the general formula (Wherein R represents a hydrocarbon group, a hydrocarbon group containing an oxygen atom or a protecting group for an organosilicon group) represented by the following formula:
7. The method for producing a galantamine-type amaryllidaceae alkaloid according to claim 6, wherein the reaction is carried out with bis (trifluoroacetate) to form an intramolecularly coupled product.
【請求項8】 請求項7のカップリング反応により得ら
れた次式 【化5】 (式中のRは、炭化水素基または酸素原子が含まれる炭
化水素基もしくは有機ケイ素基の保護基を示す)の分子
内カップリング体化合物を、芳香環部の脱保護反応によ
り次式 【化6】 の化合物に導き、フェノール性水酸基をトリフルオロメ
タンスルフォニル化により次式 【化7】 の化合物に導き、トリフラート基を還元的脱離反応によ
り次式 【化8】 の化合物を製造するガランタミン型ヒガンバナアルカロ
イド類の製造方法。
8. The following formula obtained by the coupling reaction according to claim 7. (Wherein R represents a hydrocarbon group, a hydrocarbon group containing an oxygen atom, or a protecting group for an organosilicon group). 6] And the phenolic hydroxyl group is converted to the following formula by trifluoromethanesulfonylation. And the triflate group is subjected to a reductive elimination reaction by the following formula: A method for producing galantamine-type amaryllidaceae alkaloids for producing the compound of formula (I).
【請求項9】 請求項8の方法により得られた化合物よ
り、そのカルボニル基の立体選択的還元とホルミル基の
還元により、次式 【化9】 のガランタミン(galanthamine)を製造す
るガランタミン型ヒガンバナアルカロイド類の製造方
法。
9. A compound obtained by the method of claim 8, wherein the carbonyl group is stereoselectively reduced and the formyl group is reduced to give the following compound: A method for producing galantamine-type amaryllidaceae alkaloids for producing galantamine.
【請求項10】 請求項8の方法により得られた化合物
より、そのカルボニル基をアセタール化により、一般式 【化10】 (式中のRは炭化水素を示す)、の環式または非環式ア
セタール体の化合物に導きホルミル基の還元とアセター
ル基の加水分解反応により、次式 【化11】 のナルウエジン(narwedine)を製造するガラ
ンタミン型ヒガンバナアルカロイド類の製造方法。
10. The compound obtained by the method of claim 8 wherein the carbonyl group is acetalized to give a compound of the general formula (Wherein R represents a hydrocarbon), and the compound is converted into a cyclic or acyclic acetal compound by reducing the formyl group and hydrolyzing the acetal group to obtain the following formula: A method for producing galantamine-type amaryllidaceae alkaloids for producing narwedine.
【請求項11】 請求項9の方法により得られた化合物
より、そのオレフィン部位を水素還元して次式 【化12】 のリコラミン(lycoramine)を製造するガラ
ンタミン型ヒガンバナアルカロイド類の製造方法。
11. The compound obtained by the method according to claim 9, wherein the olefin site thereof is hydrogen-reduced to obtain the following formula: A method for producing galantamine-type amaryllidaceae alkaloids for producing lycoramine.
【請求項12】 請求項8の方法により得られた化合物
より、そのホルミル基の加水分解とカルボニル基の立体
選択的還元反応により、次式 【化13】 のノルガランタミン(norgalanthamin
e)を製造するガランタミン型ヒガンバナアルカロイド
類の製造方法。
12. The compound obtained by the method of claim 8 by hydrolysis of the formyl group and a stereoselective reduction reaction of the carbonyl group to obtain the following compound: Norgalantamine
A method for producing galantamine-type amaryllidaceae alkaloids for producing e).
【請求項13】 請求項8の方法により得られた化合物
より、そのメトキシ基の脱メチル化の後、ホルミル基の
還元とカルボニル基の立体選択的還元反応により、次式 【化14】 のサンギニン(sanguinine)を製造するガラ
ンタミン型ヒガンバナアルカロイド類の製造方法。
13. The compound obtained by the method according to claim 8, wherein after demethylation of the methoxy group, reduction of the formyl group and stereoselective reduction of the carbonyl group give the following formula: A method for producing galantamine-type amaryllidaceae alkaloids for producing sanguinine.
JP2000339731A 2000-10-02 2000-10-02 Method for producing galanthamine type lycoris alkaloids Pending JP2002114791A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2000339731A JP2002114791A (en) 2000-10-02 2000-10-02 Method for producing galanthamine type lycoris alkaloids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000339731A JP2002114791A (en) 2000-10-02 2000-10-02 Method for producing galanthamine type lycoris alkaloids

Publications (1)

Publication Number Publication Date
JP2002114791A true JP2002114791A (en) 2002-04-16

Family

ID=18814763

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000339731A Pending JP2002114791A (en) 2000-10-02 2000-10-02 Method for producing galanthamine type lycoris alkaloids

Country Status (1)

Country Link
JP (1) JP2002114791A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104592243A (en) * 2014-12-19 2015-05-06 北京大学 Asymmetric synthesis method of galanthamine and lycoramine
CN111743957A (en) * 2019-03-29 2020-10-09 泰州医药城国科化物生物医药科技有限公司 Selective enrichment method for preparing alkaloid compounds from traditional Chinese medicine lycoris radiata

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104592243A (en) * 2014-12-19 2015-05-06 北京大学 Asymmetric synthesis method of galanthamine and lycoramine
CN111743957A (en) * 2019-03-29 2020-10-09 泰州医药城国科化物生物医药科技有限公司 Selective enrichment method for preparing alkaloid compounds from traditional Chinese medicine lycoris radiata

Similar Documents

Publication Publication Date Title
EP3483161B1 (en) Intermediates used to make entecavir
JPH01305076A (en) Preparation of taxol
TWI666211B (en) Method for preparation of quibetin and the intermediate thereof
Chandrasekhar et al. Practical and highly stereoselective approaches to the total synthesis of (−)-codonopsinine
JP2012509267A (en) (R) -3- (2,3-dihydroxypropyl) -6-fluoro-5- (2-fluoro-4-iodophenylamino) -8-methylpyrido [2,3-d] pyrimidine-4,7 (3H , 8H) -Dione and processes for its production
JP2002114791A (en) Method for producing galanthamine type lycoris alkaloids
CA2569266A1 (en) Process to prepare camptothecin derivatives and novel intermediate and compounds thereof
CA3223714A1 (en) Process for the preparation of a cyp11a1 inhibitor and intermediates thereof
JP5587350B2 (en) Preparation of ramelteon
CN108084146B (en) Preparation method of ecteinascidin-743 intermediate
CN104974052B (en) Preparation method of tetrahydroisoquinoline compound intermediate
US6335458B1 (en) Intermediate compounds in the synthesis of the A ring moiety of 2-substituted vitamin D derivatives
KR900000967B1 (en) Benzylamine derivatives and their preparation
JP3259191B2 (en) Synthesis of 2,2&#39;-anhydroarabinosyl thymine derivatives
JP2005314260A (en) Method for producing flavone c glycoside
CN114805168B (en) Pyrrolinones and synthesis method thereof
EP2861572B1 (en) Improved process for the preparation of 2-substituted-2-(6-(substituted)-7-methylbenzo[d][1,3]dioxol-4-yl)acetic acid derivatives
US7705155B2 (en) Processes for the production of useful intermediates
JP2011520876A (en) Process for the production of chiral intermediates for the production of HMG-CoA reduction inhibitors
JPH0511114B2 (en)
JP6205530B2 (en) Method for producing side chain precursor of paclitaxel and docetaxel
EP0214905A2 (en) Tetrahydroisoquinoline derivatives
CN102775402B (en) A kind of intermediate preparing dihydrolysergic acid and preparation method thereof
JP2752489B2 (en) Novel macrocyclic compound and method for producing the same
CN115322106A (en) Synthesis method of trans-3-azido-1-methylcyclobutanol and trans-3-amino-1-methylcyclobutanol